The Company has received some shareholder inquiries about whether the Company will be presenting at the SMi conference in London on September 27-28, 2017. While anticipating the disclosure of interim blinded data from the Company's Phase 3 trial of DCVax-L for Glioblastoma, the Company will not be presenting at this years SMi conference. SMi will be posting this same information on their website and in the conference program.
What does this mean? Why can't they communicate like every other company? LP is quite adept as speaking english. Isn't she? Why so vague? So now mb posters are off to the races..again.. trying to figure out the meaning of, "While anticipating the disclosure of interim blinded data from the Company's Phase 3 trial of DCVax-L for Glioblastoma...".
It appears they were "anticipating the disclosure of interim blinded data from the Company's Phase 3 trial of DCVax-L". But, at the last minute, 4 days prior to the event LP cancels. Why? any idea when the data will be released? While longs, starving for info, are ecstatic about the disclosure of "interim blinded data", Does anyone even know what "interim blinded data" means? I thought there were no interim analysis done.
On the rare occasions when NWBO provides info, it always seems to result in way more questions than answers. By design?
Market Data 
Markets 
AI
